I have recorded another podcast with fellow investor and good friend Roland Head. This time we talked about James Halstead, the vinyl-flooring specialist that has lifted its dividend for 45 consecutive years. We discussed the company’s Polyflor product, its competitive position, the old-school family management and why the share features on our watch lists:
A satisfactory performance, with H1 revenue reaching a new £38m high, H1 profit gaining 8% and the welcome declaration of a £7m special dividend.
Assisted by strong Italian progress, European revenue climbed 17% to represent 27% — a record proportion — of the total top line.
A healthy 22% margin and favourable cash conversion lifting net cash to £34m left the accounts in good shape.
A bombshell delisting on AIM brings greater attention to ASY’s 90% family ownership and the associated ‘relationship agreement’ small-print.
The 10% free float may explain why the shares yield a useful 4.7% despite the robust financials, upbeat company-blog commentary and potential further European expansion. I continue to hold.
Happy Easter! I trust your shares have enjoyed a positive start to the year following the rough conditions of 2022.
A summary of my portfolio’s first quarter:
Q1 return: +1.9% gain* (FTSE 100: +3.6% gain).
Q1 trades: None.
Q1 winners/losers: 6 winners vs 4 losers (1 unchanged).
(*Performance calculated using quoted bid prices and includes all dealing costs, withholding taxes, broker-account fees, paid dividends and cash interest)
I will gladly take a 1.9% gain for this Q1 after the 23% mauling I suffered last year. My portfolio now requires ‘only’ a further 28% advance to revisit its all-time high from December 2021.
Company RNSs were generally very acceptable during the quarter. Dividends were held or raised and thankfully no profit warnings emerged. As always I am hopeful a mix of respectable competitive positions, capable managers and asset-rich balance sheets will steer my portfolio through whatever the markets may bring.
Notice of general meeting summary for System1(SYS1):
Confirmation of a vote on 21 April to i) appoint former director Stefan Barden as executive chairman; ii) demote founder John Kearon from executive to non-executive, and; iii) retire two non-executives.
Data and Data-led revenue advancing 33% during FY 2023 and 50%-plus during Q4 2023 suggests SYS1’s mooted 25% growth target is achievable.
My conversation with Mr Barden revealed his data-platform sales focus, plans for a £100m-plus exit and the reasoning behind SYS1’s $1 billion market-cap ambition.
SYS1’s proposed new US advisory team emphasised Mr Kearon’s advert-creative sales approach, which I now believe explains the group’s lowly revenue and lack of profit.
Shareholders have, according to Mr Barden, a “now or never” decision to support SYS1 becoming the “definitive” marketing-data platform with a potential 5-bagger outcome. I still support the proposed board changes and continue to hold.
I have recorded another podcast with my good friend Roland Head. This time we talked about Roland’s shareholding in ITV, which currently yields 6% for his income portfolio. We discussed the broadcaster’s business strategy, growth opportunities, industry challenges and lowly valuation:
A seemingly lower-than-normal bad-debt charge underpinned a record H1 performance, which in turn supported fresh highs for net asset value (NAV) and the dividend.
Mixed signals remain at the primary motor-finance division, with encouraging collection rates offset by lingering pandemic-related provisions and talk of “choppy waters ahead” testing “policies and procedures“.
Bumper progress at the property-loan operation heralded the subsidiary declaring its maiden dividend and another divisional executive appointed to the board.
Debt remains under control at 42% of customer loans, although admin and other costs have reached their highest combined proportion of revenue since at least FY 2016.
Management’s webinar commentary cited a broker’s £33 price target, with subsequent RNSs suggesting the £22 shares are not expensive at a potential 1.17x NAV with a 6% income. I continue to hold.
***ShareScope New Subscriber Special Offer*** Readers of my blog can enjoy a 20% first-year discount! Click here for details >>
18 March 2023 By Maynard Paton
You can become a better investor by occasionally visiting the stock-market graveyard.
One company that now seems destined for the cemetery is WANdisco, the software developer that the other week suddenly warned of “significant, sophisticated and potentially fraudulent irregularities“.
The shares have been suspended while independent investigators work out what exactly has occurred. Remarks including “significant going concern issues” make for grim reading:
“The identification of these irregularities will significantly impact the Company’s cash position and lead to a material uncertainty regarding its overall financial position and significant going concern issues. The Board now expects that anticipated FY22 revenue could be as low as USD 9 million and not USD 24 million as previously reported. In addition, the Company has no confidence in its announced FY22 bookings expectations.“
H1 2023 revenue falling 15% to FY 2012 levels and underlying cash losses running at £2m-plus raised further doubts about SYS1’s services, marketing, pricing and expenditure.
Despite encompassing “all strategic options” and the board’s composition, a three-month strategic review simply “validated” SYS1’s existing plans with a greater focus on the United States.
A management presentation revealed the transition to automated Data services still requires old-style consultancy work, and overlooked questions about partnerships, cash flow and expenses.
The unsatisfactory H1, underwhelming strategic review and frustrating Q&A were thankfully followed by two former executives proposing very welcome board changes.
Fresh executive leadership seems needed to maximise SYS1’s “superb, proven suite of products” and re-establish worthwhile levels of profit. I support the proposed board changes and continue to hold.
I have recorded another podcast with my good friend Roland Head. This time we talked about Telecom Plus, the FTSE 250 reseller of utilities that appears to be a beneficiary of higher energy bills. We discussed the group’s appealing growth record, upbeat future prospects, unusual marketing approach and dividend income potential:
A very satisfactory performance buoyed by healthy post-pandemic orders, showing revenue up 27% and profit up 18% to set new H1 records.
Positive progress was reported throughout the group, with construction-related sales up 55% helped by greater demand for specialist drilling.
The long-awaited Greenhammer system has won its first commercial contract and now offers “transformational potential” to MCON and the mining industry.
Greenhammer and other new developments may hopefully improve MCON’s financials, given the group’s modest margin, significant stock level, net debt and poor cash conversion.
The shares do not appear outrageously expensive on a possible 16x P/E, although the group’s expansion led by the dominant family owners has yet to deliver superior returns to outsiders. I continue to hold.
A record FY outcome (profit +29%) bolstered by the acquisition of Spanish firm Zemper that supported TFW’s 20th consecutive annual dividend increase.
Progress at Thorlux was supported by impressive SmartScan sales (+49%), with the innovative lighting system reducing running costs for customers by as much as 62%.
A positive Dutch performance has led to a reassuring non-exec appointment and an encouraging start within the electric-vehicle charging market.
Net cash of £39m may arguably be only £9m following the subsequent purchase of TFW’s largest customer plus the eventual earn-out for Zemper.
A possible 24x P/E seemingly reflects TFW’s healthy order book, savvy acquisition approach, distinguished operating history and growth opportunities beyond the UK and lighting. I continue to hold.
I have recorded a podcast with my good friend Roland Head. This time we talked about Bioventix, the antibody specialist that at the start of 2023 represented my largest shareholding. We discussed the wonderful economics of antibodies, information gleaned from the AGM and the research into testing for Alzheimer’s Disease:
Rhys Thomas: “Maynard, I have really enjoyed reading your column, and your original contributions back in the TMF days. Many thanks for…” 30 Mar 2026
Roger: “I’m late to the party with my comments – apologies. I’m sorry that you have to stop and enjoyed reading…” 27 Mar 2026
Johnny boy: “Maynard, I have really enjoyed reading you write-ups over the years. Please don’t lose your passion for individual stock picking.…” 16 Mar 2026
NIGEL: “Maynard I would also like to thank you for all the work you have done over the years. I have…” 25 Feb 2026
James H: “Hi Maynard, I’d like to put on record my thanks to you for all of the content over recent years.…” 14 Jan 2026
Zach: “Hello Maynard, You may or may not remember me. I joined the company you retired from just a month or…” 09 Jan 2026
Simon Brenncke: “Thanks for this instructive summary of your portfolio developments, and all the best!” 09 Jan 2026
Anonymous: “Thank you for such meticulous and fascinating insight over the years. I’ve only followed your output relating to one company…” 07 Jan 2026